The Effect of Tofogliflozin Treatment on Postprandial Glucose and Lipid Metabolism in Japanese Men With Type 2 Diabetes: A Pilot Study

BACKGROUND: Postprandial hyperglycemia and hyperlipidemia are highly related to the development of atherosclerosis. Sodium/glucose cotransporter-2 (SGLT2) inhibitors have attracted attention as a new class of anti-diabetic agents for the treatment of type 2 diabetes. We investigated the effect of to...

Descripción completa

Detalles Bibliográficos
Autores principales: Kakuda, Hirokazu, Kobayashi, Junji, Sakurai, Masaru, Kakuda, Masahiro, Takekoshi, Noboru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5380173/
https://www.ncbi.nlm.nih.gov/pubmed/28392860
http://dx.doi.org/10.14740/jocmr2806w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5380173/
https://www.ncbi.nlm.nih.gov/pubmed/28392860
http://dx.doi.org/10.14740/jocmr2806w

Ejemplares similares